BGLC Earnings
Latest Revenue76.2K
Latest Net Income-286451
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q2 2026 | -$0.12 | 76.2K | -286451 | -96.6% | +64.7% |
| Q1 2026 | -$0.23 | 22.8K | -543575 | -98.9% | +34.3% |
| Q4 2025 | -$0.51 | 483.8K | -1036117 | -80.8% | -5,000.0% |
| Q3 2025 | -$0.40 | 2.5M | -708991 | -3.3% | +46.7% |
| Q2 2025 | -$0.34 | 2.3M | -616172 | +14.5% | -409.1% |
| Q1 2025 | -$0.35 | 2.1M | -623327 | -10.3% | -3,400.0% |
| Q4 2024 | -$0.01 | 2.5M | -348319 | +11.0% | -150.0% |
| Q3 2024 | -$0.75 | 2.6M | -1345370 | +3.0% | +52.2% |
| Q2 2024 | $0.11 | 2.0M | 199.1K | — | — |
| Q1 2024 | -$0.01 | 2.4M | -103757 | — | — |
| Q4 2023 | $0.02 | 2.3M | 308.5K | — | — |
| Q3 2023 | -$1.57 | 2.6M | -2609189 | — | — |
BioNexus Gene Lab (BGLC) — Earnings